Published online Aug 26, 2021. doi: 10.12998/wjcc.v9.i24.7110
Peer-review started: December 21, 2020
First decision: May 5, 2021
Revised: May 25, 2021
Accepted: July 2, 2021
Article in press: July 2, 2021
Published online: August 26, 2021
Processing time: 245 Days and 22.6 Hours
Extramedullary plasmacytoma (EMP), a variant form of myeloma, is a rare solid plasma cell tumor that originates from the bone marrow hematopoietic tissue and accounts for about 3% of all plasma cell tumors. EMP can affect various tissues and organs, about 90% of which is found in the head and neck. However, EMP in the reproductive organs is rare, and is difficult to be distinguished from other primary or metastatic genital tumors according to clinical symptoms and imaging findings.
Herein, we report a case with coexistence of EMP and squamous cell carcinoma in the cervix. The first histopathological report of neoplasms on the surface of the cervix and vagina showed an EMP. Both ultrasound and pelvic enhanced magnetic resonance imaging (MRI) indicated that there was a tumor in the cervix. Thus, another cervical biopsy and pathological examination were performed, which indicated EMP combined with squamous cell carcinoma. Then, the patient underwent extensive total hysterectomy (type C1) + systemic lymph node dissection and received 25 external pelvic irradiations with a dose of 50 Gy following surgery. During 2-year follow-up, no recurrence was reported.
In conclusion, EMP involving the reproductive system is relatively rare. In this case, MRI, B-ultrasound, and cervical canal scraping were used to further determine the diagnosis of EMP combined with squamous cell carcinoma. The patient had improved prognosis after appropriate treatments.
Core Tip: Extramedullary plasmacytoma (EMP) is a plasma cell tumor that occurs outside the bone marrow. EMP in the reproductive organs is rare, and is difficult to distinguish from other primary or metastatic genital tumors or is easily missed. Herein, we describe a case with coexistence of EMP and squamous cell carcinoma in the cervix. Magnetic resonance imaging (MRI), B-ultrasound, and cervical canal scraping were used to further determine the diagnosis of EMP combined with squamous cell carcinoma. The patient had improved prognosis after appropriate treatments. This report suggests that screening with vaginal ultrasound and enhanced MRI can help to avoid misdiagnosis.